Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.

¥5.08As of Sun 8 Nov 2026, 12:00 UTC
SSE:603168Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (14.21%)
Div yield —
ROE (22.84%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.20
PE TTM —
TSR TTM (36.50%)
Mkt cap ¥1.901B
ROIC (5.88%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥6.25
23.10%
(88.54%)
Hold 0|3|1|2|2
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.05
0.05
0.05
0.05
0.20%
(0.83%)
3.84%
9.85%
Revenue¥M
199.0
204.5
198.8
194.2
2.95%
5.68%
3.86%
3.10%
Peers (US$284.9M)
Cap (US$)
PE
281.3M
—
Capital
TTM
5Y
10Y
Leveragex
1.094
2.802
1.901
EBIT/Intx
0.191
0.303
0.254
Own earn%
40.31
(90.10)
(88.56)
Sh yield%
37.90
22.85
20.76
Owners
Insiders/Inst%
8.37
78.05
Short interest%
2.26
SBC / revenue%
0.68
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
4–9
$1 testx
−0.1
Incr. ROIC%
3